You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
翌聖生物上會突遭取消!上交所打響“從嚴審覈”核酸檢測企業上市首槍
格隆匯 11-27 11:34
格隆匯11月27日丨據上交所網站消息,近日,因尚有相關事項需要進一步覈查,翌聖生物被取消發行上市申請的審議。業內人士稱,原定於11月25日上會的翌聖生物遭遇“取消審覈”,或許跟近期涉核酸檢測企業扎堆IPO引發監管關注有關。 11月21日,滬深交易所就部分擬IPO公司業務和收入涉及核酸檢測等相關話題回答記者問時表示,高度關注涉核酸檢測企業的上市申請,堅持從嚴審覈,重點關注企業的可持續經營能力。 翌聖生物正是滬深交易所作出上述迴應後首家涉核酸檢測業務的上會公司。招股書顯示,2020年度、2021年度和2022年1-6月,翌聖生物與新冠相關的產品銷售收入分別爲4614.76萬元、8174.13萬元和7689.73萬元,佔當期營業收入的比例分別爲24.77%、25.42%和38.28%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account